Citations: Bruno,Silvia; Fabbi,Marina; Tiso,Micaela; Santamaria,Barbara; Ghiotto,Fabio; Saverino,Daniele; Tenca,Claudya; Zarcone,Daniela; Ferrini,Silvano; Ciccone,Ermanno; Grossi,Carlo E.. Cell activation via CD44 occurs in advanced stages of squamous cell carcinogenesis. Carcinogenesis 2000;21:893-900. (Link)
Van Hal,Nicole L.W.; van Dongen,Guus A.M.S.; Ten Brink,Corlinda B.M.; Heider,Karl Heinz; Rech-Weichselbraun,Irene; Snow,Gordon B.; Brakenhoff,Ruud H.. Evaluation of Soluble CD44v6 as a Potential Serum Marker for Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research 1999;5:3534-3541. (Link)
Franzmann,Elizabeth J.; Reategui,Erika P.; Carraway,Kermit L.; Hamilton,Kara L.; Weed,Donald T.; Goodwin,W.Jarrard. Salivary Soluble CD44: A Potential Molecular Marker for Head and Neck Cancer. Cancer Epidemiology Biomarkers & Prevention 2005;14:735-739. (Link)
Scott,David A.; Stapleton,John A.; Palmer,Richard M.; Wilson,Ron F.; Sutherland,Gay; Coward,Paula Y.; Gustavsson,Gunnar; Odell,Edward W.; Poston,Robin N.. Plasma Concentrations of Reputed Tumor-associated Soluble CD44 Isoforms (v5 and v6) in Smokers Are Dose Related and Decline on Smoking Cessation. Cancer Epidemiology Biomarkers & Prevention 2000;9:1211-1214. (Link)
Sconocchia,G.; Titus,J.A.; Segal,D.M.. CD44 is a cytotoxic triggering molecule in human peripheral blood NK cells. The Journal of Immunology 1994;153:5473-5481. (Link)
Tibesku,C.O.; Szuwart,T.; Ocken,S.A.; Skwara,A.; Fuchs,S.. Expression of the matrix receptor CD44v5 on chondrocytes changes with osteoarthritis: an experimental investigation in the rabbit. Annals of the Rheumatic Diseases 2006;65:105-108. (Link)
CHUANG,C.K.; SHEN,Y.C.; WU,J.H.; TSAI,L.H.; LIAO,S.K.. IMMUNOBIOLOGIC, CYTOGENETIC AND DRUG RESPONSE FEATURES OF A NEWLY ESTABLISHED CELL LINE (SCRC-1) FROM RENAL SMALL CELL... The Journal of urology 2000;163:1016-1021. (Link)
Lee,Shih Chun; Harn,Horng Jyh; Lin,Torng Sen; Yeh,Kun Tu; Liu,Yao Chi; Tsai,Chien Sung; Cheng,Yeung Leung. Prognostic significance of CD44v5 expression in human thymic epithelial neoplasms. Annals of Thoracic Surgery 2003;76:213-218. (Link)
Leth-Larsen,Rikke; Lund,Rikke; Hansen,Helle V.; Laenkholm,Anne Vibeke; Tarin,David; Jensen,Ole N.; Ditzel,Henrik J.. Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry. Molecular and Cellular Proteomics 2009;M800061-MMCP200. (Link)
Bankfalvi; Terpe,H.J.; Breukelmann,D.; Bier,B.; Rempe,D.; Pschadka,G.; Krech,R.; Bocker,W.. Gains and losses of CD44 expression during breast carcinogenesis and tumour progression. Histopathology 1998;33:107-116. (Link)
Sarli,Giuseppe; Sassi,Francesco; Brunetti,Barbara; Rizzo,Antonio; Diracca,Laura; Benazzi,Cinzia. Lymphatic vessels assessment in feline mammary tumours. BMC Cancer 2007;7:7-7. (Link)
Berner,H.S.; Suo,Z.; Risberg,B.; Villman,K.; Karlsson,M.G.; Nesland,J.M.. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas. Histopathology 2003;42:546-554. (Link)
